$AVGO

Why Broadcom CEO Hock Tan Called Anthropic and OpenAI 'Two Geniuses in the Middle of Mongolia'

Broadcom (AVGO) CEO Hock Tan compared AI companies Anthropic and OpenAI to 'geniuses in Mongolia' needing help. The company is financing their AI infrastructure via its XPV platform, with a $35B deal closed for Anthropic. Tan expects Anthropic to surpass Google as Broadcom's top AI chip customer by 2027. Broadcom reported Q3 revenue of $29.59B, beating estimates, but Q4 guidance was slightly below expectations.

Original reporting
Published Sep 3, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 11:22 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Broadcom CEO Hock Tan Called Anthropic and OpenAI 'Two Geniuses in the Middle of Mongolia' — source image
Decision brief

The 30-second read

$AVGOBullishMed
01

Why it matters

The financing deal expands Broadcom’s revenue stream beyond chip sales, positioning it as a key backer of AI compute growth.

02

Market read

Broadcom’s earnings beat and new $35 B AI financing tranche provide fresh material for traders evaluating AI‑related semiconductor exposure.

03

What to watch

Potential dilution of Broadcom’s balance sheet and reliance on a few AI customers.

Relevance 7/10Novelty 8/10Timing: post‑earnings today

Background

Broadcom’s Q3 earnings beat revenue and EPS estimates, but guidance fell short, while the company announced a major financing vehicle for AI startups.

Company-level read

Ticker impact

$AVGOBullishHigh confidence
Context

Broadcom disclosed a $35 billion first tranche financing tied to Anthropic’s AI compute deployment during its Q3 earnings call.

Expected impact

Potential modest upside as the market prices in higher AI-related revenue, but short‑term volatility may persist due to earnings beat and guidance miss.

Evidence & confidence

The $35 B tranche is a material, previously undisclosed amount that directly affects Broadcom’s growth outlook and cash flow.

Market effects

Highlights growing demand for AI infrastructure financing, benefiting semiconductor and XPU providers.

U.S. tech sector may see a slight lift as AI‑related financing gains visibility.

Signals broader investor interest in AI compute financing across markets.

Counterpoint

The financing exposure could increase risk if Anthropic or OpenAI face slower growth or regulatory hurdles.

Key entities

  • Broadcom Inc.

    Semiconductor maker reporting Q3 results and AI financing.

  • Anthropic

    AI startup receiving financing from Broadcom’s XPV platform.

  • OpenAI

    AI startup also financed via Broadcom’s XPV platform.

Related articles

$AVGOHighAI 8/10

Wall Street Breakfast Podcast: Broadcom Beat Meets High Hopes

Broadcom (AVGO) shares fell 2.1% premarket despite beating Q3 earnings expectations, as weaker-than-expected guidance overshadowed results. Revenue rose 86% YoY to $29.59B, but Q4 revenue guidance of $34.8B missed estimates. Chipotle (CMG) opened its first Asian restaurant in Seoul, South Korea, and plans further expansion. The DOJ is investigating major grocery retailers over beef pricing. Snowflake (SNOW) shares surged 24% after strong Q2 results and upbeat outlook.

$AVGOMed

Macquarie upgrades Broadcom on Anthropic compute ramp

Macquarie upgraded Broadcom (AVGO) to outperform, citing reduced risk from Google insourcing and exposure to Anthropic's compute growth. Analyst Arthur Lai expects Anthropic to spend over $40B with Broadcom by fiscal 2028. Q3 revenue rose 33% to $29.6B, with net profit beating estimates. Macquarie raised its price target to $490, implying a 35% return.

$AVGOMed

Broadcom slips as soft Q4 guide overshadows strong growth outlook: Buy the dip?

Broadcom (AVGO) shares fell 3.51% premarket to $354.36 after Q4 revenue guidance of $34.8B missed consensus of $35.05B, despite Q3 revenue and EPS beating estimates. Long-term growth targets remain high, with AI revenue expected to reach $115B in 2027 and $230B in 2028. Analysts note risks including customer concentration and supply constraints. The stock trades at a forward P/E of 30.5x, with FinQL's fair value estimate at $415.73, suggesting 13.2% upside.

$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on

$AVGOMed

Broadcom's AI chip bet raises questions over who foots the bill

Broadcom (AVGO) reported Q3 earnings beating expectations but shares fell 0.8% due to a lower-than-expected Q4 revenue forecast of $34.8B. CEO Hock Tan aims to double AI revenue to $115B by 2027 and $230B by 2028. CFO Amie Thuener noted potential 'residual value guarantees' for AI labs, indicating chipmakers may underwrite some financial risk for customers.